Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
0 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
40681
Data_Sheet_1_Associations Between Nutritional Deficits and Physical Performance in Community-Dwelling Older Adults.docx
Published 2021“…Baseline nutritional deficits were defined as plasma 25 hydroxyvitamin D <20 ng/ml, plasma homocysteine >14 μmol/L, or erythrocyte omega-3 PUFA index ≤ 4.87% (lower quartile). …”
-
40682
Table_3_Cardiac Shock Wave Therapy in Coronary Artery Disease: A Systematic Review and Meta-Analysis.DOCX
Published 2022“…Seven studies with 312 patients reported left ventricular internal diameter in diastole (LVIDd) were markedly decreased in the CSWT group compared to the control group (WMD −1.81, 95% CI −3.23 to −0.39, p = 0.012, I<sup>2</sup> = 20.3%). …”
-
40683
Table_1_Cardiac Shock Wave Therapy in Coronary Artery Disease: A Systematic Review and Meta-Analysis.DOCX
Published 2022“…Seven studies with 312 patients reported left ventricular internal diameter in diastole (LVIDd) were markedly decreased in the CSWT group compared to the control group (WMD −1.81, 95% CI −3.23 to −0.39, p = 0.012, I<sup>2</sup> = 20.3%). …”
-
40684
Table_2_Cardiac Shock Wave Therapy in Coronary Artery Disease: A Systematic Review and Meta-Analysis.DOCX
Published 2022“…Seven studies with 312 patients reported left ventricular internal diameter in diastole (LVIDd) were markedly decreased in the CSWT group compared to the control group (WMD −1.81, 95% CI −3.23 to −0.39, p = 0.012, I<sup>2</sup> = 20.3%). …”
-
40685
Supplementary Material for: Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Clinical Practice of Single Center: Three-Year Outcomes
Published 2021“…However, when initial VA was 20/40 and better, a non-statistically significant change in mean VA by +2.0, −3.5, and −3.6 letters were noted at the same time point (<i>p</i> value between 0.078 and 0.273). …”
-
40686
-
40687
-
40688
-
40689
Body composition, blood glucose, and serum factors in C57BL/6 mice following 21 weeks of diet treatment.
Published 2014“…<p>Calorie restriction (CR) decreased A, body weight (reported up to 20 weeks on diets, before tumor cell injection); B, percent body fat (at 21 weeks on diet); and C, fasting blood glucose (at 21 weeks on diet) relative to CON diet (n = 15/group). …”
-
40690
Overexpression of <i>hsf-1</i><sup><i>neuro</i></sup> in neurons activates a fat remodeling transcriptional program that resembles one activated by worms acclimated at 25°C.
Published 2021“…<b>(I)</b> Overlaid GFP fluorescence and DIC images taken at 20× magnification. <b>(J)</b> Average GFP fluorescence intensity driven by the <i>fat-6</i> promoter is decreased by 51% in <i>hsf-1</i><sup><i>neuro</i></sup> <i># 2</i> (MOC299) compared to controls (BX115, compare mean intensity of 36.6 +/− 2.5 versus 18.8 +/−0.99). …”
-
40691
Table_1_Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials....
Published 2022“…Results suggested that metformin significantly decreased the HbA1c level at 12 months (mean difference [MD])=-0.50, 95% confidence interval [CI]=-0.61 to -0.39, P < 0.01); BMI (kg/m<sup>2</sup>) at 3 months (MD=-1.05, 95%CI=-2.05 to -0.05, P=0.04); BMI z-score at 6 months (MD=-0.10, 95%CI=-0.14 to -0.06, P<0.01); and TIDD at 3 (MD=-0.13, 95%CI=-0.20 to -0.06, P<0.01), 6 (MD=-0.18, 95%CI=-0.25 to -0.11, P<0.01), and 12 (MD=-0.42, 95%CI=-0.49 to -0.35, P<0.01) months but significantly increased the risk of hypoglycemia events (risk ratio [RR]=3.13, 95%CI=1.05 to 9.32, P=0.04) and GIAEs (RR=1.64, 95%CI=1.28 to 2.10, P<0.01). …”
-
40692
Table_2_Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials....
Published 2022“…Results suggested that metformin significantly decreased the HbA1c level at 12 months (mean difference [MD])=-0.50, 95% confidence interval [CI]=-0.61 to -0.39, P < 0.01); BMI (kg/m<sup>2</sup>) at 3 months (MD=-1.05, 95%CI=-2.05 to -0.05, P=0.04); BMI z-score at 6 months (MD=-0.10, 95%CI=-0.14 to -0.06, P<0.01); and TIDD at 3 (MD=-0.13, 95%CI=-0.20 to -0.06, P<0.01), 6 (MD=-0.18, 95%CI=-0.25 to -0.11, P<0.01), and 12 (MD=-0.42, 95%CI=-0.49 to -0.35, P<0.01) months but significantly increased the risk of hypoglycemia events (risk ratio [RR]=3.13, 95%CI=1.05 to 9.32, P=0.04) and GIAEs (RR=1.64, 95%CI=1.28 to 2.10, P<0.01). …”
-
40693
-
40694
-
40695
-
40696
-
40697
-
40698
-
40699
Prevention of Obesity and Hyperlipidemia by Heptamethoxyflavone in High-fat Diet-induced Rats
Published 2019“…The supplementation of HMF not only significantly decreased body weight gain (HFD, 336.50 ± 18.84 g; LHMF, 309.43 ± 20.74 g; MHMF, 296.83 ± 13.88 g; HHMF, 265.71 ± 19.09 g; respectively, <i>p</i> < 0.05) and adipose tissues weight (<i>p</i> < 0.05), but also markedly lowered serum levels of total cholesterol, triacylglycerol, and low-density lipoprotein cholesterol (<i>p</i> < 0.05) in the sixth week in a dose-dependent manner compared with the HFD group. …”
-
40700